Raymond James & Associates SEATTLE GENETICS INC Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
N/A
-30,358 Closed
0 $0
Q3 2020

Nov 04, 2020
SELL
N/A
-2,123 Reduced 6.54%
30,358 $5.94 Million
Q2 2020

Jul 28, 2020
BUY
N/A
3,880 Added 13.57%
32,481 $5.52 Million
Q1 2020

Apr 21, 2020
BUY
N/A
10,431 Added 57.41%
28,601 $3.3 Million
Q4 2019

Feb 12, 2020
BUY
N/A
5,258 Added 40.72%
18,170 $2.08 Million
Q3 2019

Nov 07, 2019
SELL
N/A
-2,401 Reduced 15.68%
12,912 $1.1 Million
Q2 2019

Aug 06, 2019
SELL
N/A
-7,078 Reduced 31.61%
15,313 $1.06 Million
Q1 2019

May 06, 2019
SELL
N/A
-2,038 Reduced 8.34%
22,391 $1.64 Million
Q4 2018

Feb 11, 2019
BUY
N/A
2,326 Added 10.52%
24,429 $1.38 Million
Q3 2018

Nov 14, 2018
BUY
N/A
1,587 Added 7.74%
22,103 $1.71 Million
Q2 2018

Aug 14, 2018
BUY
N/A
11,296 Added 122.52%
20,516 $1.36 Million
Q1 2018

May 14, 2018
BUY
N/A
3,420 Added 58.97%
9,220 $483,000
Q4 2017

Feb 14, 2018
SELL
N/A
-1,150 Reduced 16.55%
5,800 $310,000
Q3 2017

Nov 13, 2017
SELL
N/A
-1,241 Reduced 15.15%
6,950 $378,000
Q2 2017

Aug 14, 2017
BUY
N/A
8,191
8,191 $424,000
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email